Unlocking Biomolecular Activity through Pd‐Catalyzed Azides Reduction
Fang Fu,Wei Xiong,Xinyan Xu,Yongjie Liu,Ming Li,Qianqian Qi,Xingyu Liu,Yuanyuan Zhang,Tian Tian,Xiang Zhou
DOI: https://doi.org/10.1002/cjoc.202400254
IF: 5.56
2024-05-24
Chinese Journal of Chemistry
Abstract:In this study, we introduce a decaging strategy utilizing Pd‐catalyzed reductive amination of azides to activate biomolecules, encompassing fluorescent probes, prodrugs, and RNA functionalities. This approach offers an efficient and controllable "OFF to ON" biological switch, enabling substantial regulatory effects even at substoichiometric levels. Comprehensive Summary Pd‐mediated bioorthogonal cleavage reactions have been extensively utilized in the activation of prodrug molecules, precise regulation of protein function, and cellular engineering. However, the availability of cleavable "caging" groups is quite limited, and their application in nucleic acid modification has seldom been reported. Herein, we introduce a method based on Pd‐catalyzed reduction amination of azides as a decaging strategy to activate the activity of biomolecules. We designed modifications on the bioactive sites with azides or their derivatives to mask the related biological function, followed by the release of biological activity through Pd‐catalyzed NaBH4 reduction amination reaction. This study has demonstrated that the strategy can effectively be used to activate bioactive molecules such as fluorescent probes, prodrugs, and to regulate the biological function of RNA, including reverse transcription extension, binding to ligands, and cleavage activity of the CRISPR‐Cas system. All results confirm that this strategy provides an efficient and controllable "OFF to ON" biological switch, capable of achieving significant regulatory effects substoichiometrically, and is expected to be extended to other biological applications.
chemistry, multidisciplinary